Results 131 to 140 of about 9,648,146 (309)

First reported case of intradural extramedullary epithelioid hemangioma of the cauda equina: resection of an extremely rare vascular neoplasm. Illustrative case. [PDF]

J Neurosurg Case Lessons
Baker A, Granelli S, Baker D, Woodall W, Lee M, Morales-Vargas B, Do H.   +6 more
europepmc   +1 more source

Vicki Karaminas at the Queer History of Fashion Symposium

Vicki Karaminas, associate professor of fashion studies and director of research at the School of Design, University of Technology, Sydney, presents "'Born This Way': Lesbian Style Since the Eighties" at The Museum at FIT's 13th fashion symposium, A ...

core  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

« Créer c’est avoir vu le premier ». Les Galeries Lafayette et la mode (1893-1969)

L'Atelier du CRH, 2018
Florence Brachet-Champsaur
doaj   +1 more source

Optoelectrical Conditioning in Graphene Quantum Dot‍-‍Vanadium Oxide Artificial Synapse. [PDF]

Small Sci
Jetty P, Kundale SS, Kim YT, Lestari WA, Lee SW, Heo J, Park JH.   +6 more
europepmc   +1 more source

2007 FIT Fashion Show: Special Occasion

FIT's fashion design seniors are the "Rising New Stars 2007." Student designs in the special occasion section are presented at the annual student fashion ...

core  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Feasibility of Transoral Robotic Total Laryngectomy With the Da Vinci Single Port Robotic System. [PDF]

Laryngoscope Investig Otolaryngol
De Witte M, Boulanger J, Lawson G, Dick C, Dochy F, Vauterin T.   +5 more
europepmc   +1 more source

2008 FIT Fashion Show: Special Occasion

"Special Occasion" garments designed by graduating students in FIT's BFA fashion design program.

core  

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source